Molecular Remission After Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Consolidation Therapy Following Double Autologous Transplantation for Multiple Myeloma: Results of a Qualitative and Quantitative AnalysisCarolina Terragna, Michèle Cavo, Francesca Patriarca et al.|Blood|2010Cited by 13
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide–dexamethasone incorporated into double autologous transplantationCarolina Terragna, Michèle Cavo, Matteo Renzulli et al.|Annals of Hematology|2013Cited by 10